Calithera Biosciences (NASDAQ:CALA) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a research note released on Monday morning. The brokerage issued a hold rating on the biotechnology company’s stock.

Calithera Biosciences Stock Performance

Shares of NASDAQ:CALA opened at $0.03 on Monday. The company’s 50-day moving average price is $0.02 and its 200 day moving average price is $0.03. Calithera Biosciences has a fifty-two week low of $0.01 and a fifty-two week high of $0.50.

About Calithera Biosciences

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.